Peter Sas

INVESTIGATING NEW REGIONS & THERAPIES: SEIZING THE OPPORTUNITIES OF AN EXPANDING CLINICAL TRIAL SUPPLY ECOSYSTEM

 How does it work? Choose a 45-minute discussion on a pressing clinical trial supply topic. Interact with your peers, identifying contemporary challenges and novel approaches to confronting them. Each roundtable is led by a subject matter expert.

 Following the conclusion of the discussions, there will be a 30-minute feedback session, where the roundtable leaders will share the key findings that came out of their respective discussions.

The discussion groups are:

GROUP A - HOW CAN WE BREAK DOWN SILOED DECISION-MAKING IN CLINICAL TRIAL SUPPLY?

GROUP B - OVERCOMING THE SUPPLY CHAIN CHALLENGES IN EMERGING CLINICAL TRIAL REGIONS

GROUP C- INDUSTRY BEST PRACTICES AND EMERGING TECH FOR A GREENER FUTURE OF CLINICAL TRIALS

GROUP D - HOW DO WE STRENGTHEN OUR SUPPLY CHAINS IN A “VUCA” WORLD?

GROUP E - INDUSTRY BEST PRACTICES TRENDING & MITIGATING TEMPERATURE DEVIATIONS

GROUP F - IDENTIFYING & USING THE BEST INDUSTRY CLINICAL SUPPLY CHAIN METRICS